In the 7-06-04 issue of Inside Bioassays, the article “BD Biosciences Strengthens its High-Content Screening Portfolio with Atto Purchase” (see Inside Bioassays, 7/6/2004), mistakenly identified Life Technologies, a company subsequently acquired by Invitrogen, as Life Sciences.
Correction
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.